Special Episode: Evolving and Emerging Trends in HER2 Classification and Reporting in Breast Cancer

episode

Inside the Lab not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Nightcap Hour 1: Broncos WALK DOWN Rams + Ravens BEAT Cowboys in Brazil + Steelers STUN Bengals 57 min · 28 Sep 2026 · Nightcap

Day 271: Love of God (2026) 20 min · 28 Sep 2026 · The Catechism in a Year (with Fr. Mike Schmitz)

Day 271: The Sorrowful Mysteries 14 min · 28 Sep 2026 · The Rosary in a Year (with Fr. Mark-Mary Ames)

Nightcap Hour 2: Deshaun Watson WINS AGAIN + Justin Herbert PLAYING Like GARBAGE +Jaguars MAN HANDLE Patriots + Lions OUTLAST Jets + Colts SEND Texans PACKING + Commanders SHOCK Seahawks + Vikings CRUISE to WIN Over Bucs 1h 6m · 28 Sep 2026 · Club Shay Shay

Seventh Generation: Alan Newman and Jeffrey Hollender. A Partnership that Flourished—until it Failed. (2021) 1h 31m · 28 Sep 2026 · How I Built This with Guy Raz

Report any issue

Source

Recorded20 Oct 2022

Publisherfeeds.buzzsprout.com

Handlerec:13802789

Show notes

The emergence of HER2-low therapies for metastatic breast cancer is a paradigm shift in the traditional binary classification of a patient’s HER2 status, creating a need for practice changes in pathology necessitated by the expansion in how HER2-low breast cancer needs to be classified and treated. During this recorded 2022 ASCP Annual Meeting session, a moderated expert faculty panel will discuss evolving and emerging trends in breast cancer classification and reporting across the HER2+ spectrum. They will also discuss how pathologists and laboratory professionals can prepare for HER2-low classification, tracking, and reporting. In addition, they will review some of the current challenges in HER2 testing and explore opportunities to prepare for the future landscape of HER classification in breast cancer. The activity offers 1.0 CME/CMLE credit. The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. FacultySwikrity U. Baskota, MDAssistant Professor, Department of Pathology, and Cell BiologyColumbia University Irving Medical Center Marilyn Bui, MD, PhDSenior Member and Professor of PathologyScientific Director of Analytic Microscopy CoreProgram Director of Cytopathology FellowshipMoffitt Cancer Center & Research Institute Mamatha Chivukula, MD, FASCPDirector of Breast Pathology Services and IHC LabMills Peninsula Medical Center, Sutter Health Affiliate Joseph Kim, MD, MBA, MPHPresidentQ Synthesis Credit Designation Statement The ASCP designates this enduring podcast activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. ASCP designates this enduring podcast activity for a maximum of 1.0 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel. For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time Method of Participation To complete the activity and receive credit, the participant must complete the podcast activity. CME certificates will be provided on-line. Commercial Support Funded by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Provided by the American Society for Clinical Pathology in partnership with Q Synthesis.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related